Skip to Content

Cipla 446 (Atazanavir Sulfate 300 mg)

Pill with imprint Cipla 446 is Red / Blue, Capsule-shape and has been identified as Atazanavir Sulfate 300 mg. It is supplied by Cipla USA Inc..

Atazanavir is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 446

Atazanavir Sulfate

Imprint
Cipla 446
Strength
300 mg
Color
Red / Blue
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0446
Inactive Ingredients
lactose monohydrate, crospovidone, magnesium stearate, gelatin, sodium lauryl sulfate, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40, D&C Yellow No. 10, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.